# Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

> **NCT03480295** · NA · COMPLETED · sponsor: **Fondazione G.B. Bietti, IRCCS** · enrollment: 39 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** Hyaluronic acid 0.4% and Taurine 0.5%
- **DEVICE:** Hyaluronic acid 0.2%

## Key facts

- **NCT ID:** NCT03480295
- **Lead sponsor:** Fondazione G.B. Bietti, IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-19
- **Primary completion:** 2017-04-27
- **Final completion:** 2017-04-27
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480295, "Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03480295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*